Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/26/2026 | 438 | 0.0% | 6,599 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 184 | 0.0% | 5,345 | 9/30/2025 |
| 2025 Q2 | 7/21/2025 | 84 | 0.0% | 5,335 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 57 | 0.0% | 4,121 | 3/31/2025 |
| 2024 Q4 | 1/27/2025 | 79 | 0.0% | 4,147 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 88 | 0.0% | 4,496 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 95 | 0.0% | 3,708 | 6/30/2024 |
| 2024 Q1 | 5/1/2024 | 8,004 | 0.0% | 327,782 | 3/31/2024 |
| 2023 Q4 | 1/24/2024 | 5,997 | 0.0% | 195,985 | 12/31/2023 |
| 2023 Q3 | 10/26/2023 | 8,017 | 0.0% | 298,370 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 9,798 | 0.0% | 274,696 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 8,399 | 0.0% | 330,658 | 3/31/2023 |
| 2022 Q4 | 2/9/2023 | 12,863 | 0.0% | 317,131 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 8,365 | 0.0% | 253,126 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 7,613 | 0.0% | 216,205 | 6/30/2022 |
| 2022 Q1 | 5/10/2022 | 6,884 | 0.0% | 149,690 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 11,731 | 0.0% | 176,925 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 9,714 | 0.0% | 155,589 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 10,339 | 0.0% | 124,836 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 7,537 | 0.0% | 113,659 | 3/31/2021 |
| 2020 Q4 | 2/10/2021 | 4,818 | 0.0% | 62,794 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 2,380 | 0.0% | 55,269 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 1,726 | 0.0% | 39,974 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 795 | 0.0% | 27,633 | 3/31/2020 |
| 2019 Q4 | 2/12/2020 | 1,408 | 0.0% | 22,190 | 12/31/2019 |